Dialogue with Prof. Aykut Üren
Didem Saraç made an interview with Prof. Aykut Üren.
Istanbul, 06 May 2020
TDG, a global leader in digital transformation, released “Dialogue Sessions” for society to accelerate digital business competitiveness.
Dialogue Sessions are aligned with the TDG’s vision statement and the latest Dialogue was done by Didem Saraç with Prof. Aykut Üren.
Now let us watch the Dr. Üren’s interview video…
Please click here to read the script of interview.
TDG invites all TDGers, students, teachers, workers, managers, industry experts, research institutes and public authorities to join the “Dialogue Session” to share their knowledge with the rest of the world…
About Prof. Aykut Üren
Dr. Aykut Üren started his research career when he was a medical student at Hacettepe University School of Medicine in Ankara, Turkey. During his medical education he took several opportunities abroad to work on the bench, where he learned how to apply basic science to clinical problems. He worked as a special volunteer with Dr. Giovanni Biasi at the University of Padova in Italy (1990) and with Dr. Stuart Aaronson in the Laboratory of Cellular and Molecular Biology at the National Cancer Institute of NIH in Bethesda, Maryland, USA (1991, 1992, 1993). In 1994 he received his MD degree from Hacettepe University and joined the Laboratory of Cellular and Molecular Biology at the National Cancer Institute, where he worked as a postdoctoral fellow for five years. He then worked at the Division of Pediatric Hematology and Oncology at the University of Maryland at Baltimore, Maryland for two years. In 2002 he joined Lombardi Comprehensive Cancer Center at Georgetown University in Washington, DC as an Assistant Professor. In 2010 he was promoted to Associate Professor with tenure and in 2015 to full professor. His primary appointment is at the Department of Oncology and his secondary appointment is at the Department of Biochemistry and Molecular & Cellular Biology. His research focuses on molecular mechanisms of malignant transformation. Some of the active projects in his laboratory include investigation of development of targeted therapies against EWS-FLI1 and CD99 in Ewing’s Sarcoma, ERG in prostate cancer, ezrin in osteosarcoma and Pax3-Foxo1 in rhabdomyosarcoma. He also runs a core facility at the Georgetown University that provides surface plasmon resonance technology (Biacore 4000 and Biacore T200). He teaches tumor biology to graduate students and gross anatomy to medical students, for which has received multiple teaching awards including Golden Apple and Golden Orchard. He serves at study sections for evaluating grant applications from the National Institutes of Health, American Cancer Society, Department of Defense, and European Commission. He also serves as an ed hoc reviewer for over two dozen international peer review journals including Cancer Research, Clinical Cancer Research, FASEB Journal, Journal of Biological Chemistry, Journal of Clinical Investigation, Molecular and Cellular Biology and Oncogene.
TDG was established to accelerate healthy technology development in society. TDG aims to be the world leader in technology development and execution in the field while providing services and solutions in consulting, system integration and business processes management.
TDG, operating in EU and US, offers services and solutions to companies from diverse sectors including manufacturing, finance, sports, health, retail, distribution, media, space, telecom and logistics with its expertise and industry knowledge in the field of technology. In Technology Development Group, people, technology and business are working together to accelerate “Proactive Innovation“ and we are a “Trusted Partner“ for organizations to create their firm of the future, and we are the best place to work for employees. Technology Development Group commits to provide high performance to its stakeholders (customers, employees, community, and shareholders) with high ethical and responsible company policies.
Press contact : Corporate Communication | email@example.com